Octreotide and low-fat breast milk in postoperative chylothorax

Area of Science:

• Pediatric Cardiology
• Thoracic Surgery
• Neonatal Medicine

Background:

• Chylothorax is a rare but serious complication following cavo-pulmonary connection surgery in infants.
• This condition can lead to significant morbidity and challenges in management.
• Conventional conservative and surgical treatments are often insufficient for severe cases.

Observation:

• A 3-month-old infant developed severe chylothorax post-bilateral cavo-pulmonary connection.
• The infant's condition was refractory to standard treatment modalities.
• This indicated a need for alternative therapeutic strategies.

Findings:

• A combination therapy of parenteral octreotide and low-fat breast milk was administered.
• This novel approach led to the resolution of the severe chylothorax.
• The treatment demonstrated efficacy in a previously refractory case.

Implications:

• Parenteral octreotide combined with dietary modification offers a promising treatment for refractory chylothorax post-cavo-pulmonary connection.
• This approach may improve outcomes for infants experiencing this rare complication.
• Further research is warranted to validate this therapeutic strategy in a larger cohort.